OtherBASIC SCIENCE INVESTIGATIONS
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Seok Rye Choi, Geoff Golding, Zhiping Zhuang, Wei Zhang, Nathaniel Lim, Franz Hefti, Tyler E. Benedum, Michael R. Kilbourn, Daniel Skovronsky and Hank F. Kung
Journal of Nuclear Medicine November 2009, 50 (11) 1887-1894; DOI: https://doi.org/10.2967/jnumed.109.065284
Seok Rye Choi
Geoff Golding
Zhiping Zhuang
Wei Zhang
Nathaniel Lim
Franz Hefti
Tyler E. Benedum
Michael R. Kilbourn
Daniel Skovronsky
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 50, Issue 11
November 2009
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Seok Rye Choi, Geoff Golding, Zhiping Zhuang, Wei Zhang, Nathaniel Lim, Franz Hefti, Tyler E. Benedum, Michael R. Kilbourn, Daniel Skovronsky, Hank F. Kung
Journal of Nuclear Medicine Nov 2009, 50 (11) 1887-1894; DOI: 10.2967/jnumed.109.065284
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Seok Rye Choi, Geoff Golding, Zhiping Zhuang, Wei Zhang, Nathaniel Lim, Franz Hefti, Tyler E. Benedum, Michael R. Kilbourn, Daniel Skovronsky, Hank F. Kung
Journal of Nuclear Medicine Nov 2009, 50 (11) 1887-1894; DOI: 10.2967/jnumed.109.065284
Jump to section
Related Articles
Cited By...
- Traumatic brain injury and Alzheimers Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)
- Amyloid-PET of the white matter: relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease
- Switching on Brain PET to Light Up Amyloid Pathology In Vivo (perspective on "In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Florbetapir F 18)" J Nucl Med. 2010;51:913-920)
- [18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
- Validation of the Semiquantitative Static SUVR Method for 18F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input Function
- Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand
- Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimers Disease with Positron Emission Tomography
- Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model
- Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir
- Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease
- In Vivo SPECT Imaging of Amyloid-{beta} Deposition with Radioiodinated Imidazo[1,2-a]Pyridine Derivative DRM106 in a Mouse Model of Alzheimer's Disease
- Structural Magnetic Resonance Imaging Markers of Alzheimers Disease and Its Retranslation to Rodent Models
- PET Approaches for Diagnosis of Dementia
- Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184
- Cortical {beta}-amyloid levels and neurocognitive performance after cardiac surgery
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- Preclinical Characterization of a Novel Class of 18F-Labeled PET Tracers for Amyloid-{beta}
- Amyloid-{beta} assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
- Fluid Biomarkers in Alzheimer Disease
- Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)